A detailed history of Kula Investments, LLC transactions in Repligen Corp stock. As of the latest transaction made, Kula Investments, LLC holds 4,856 shares of RGEN stock, worth $707,907. This represents 0.2% of its overall portfolio holdings.

Number of Shares
4,856
Holding current value
$707,907
% of portfolio
0.2%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $749,086 - $961,973
4,856 New
4,856 $818 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.09B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Kula Investments, LLC Portfolio

Follow Kula Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kula Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kula Investments, LLC with notifications on news.